Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 31 Jan 2022  |  Asia Pacific

    Enterprise Imaging Partnerships and Growth Opportunities in Selected Asia-Pacific Countries

    New Business Models Overcome Budget Restrictions to Enable Equipment Purchase and Management

    In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

    $2,450.00
  2. 11 May 2020  |  Asia Pacific

    Outlook of India’s Healthcare Industry, 2020

    Indian Healthcare Industry is Expected to Grow at 16.9% in 2020 to Reach $272.79 Billion in 2020

    The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

    $4,950.00
  3. 30 Apr 2020  |  Asia Pacific

    COVID-19—Implications for the Healthcare Industry, 2020

    Winning Strategies and Key Opportunities that are Evolving During this Disruption

    A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

    $4,950.00
  4. 14 Feb 2020  |  Asia Pacific

    Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

    New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

    This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...

    $4,950.00
  5. 07 Feb 2020  |  Asia Pacific

    Malaysian Diabetes Devices Market, Forecast to 2023

    Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

    Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...

    $3,000.00
  6. 07 Feb 2020  |  Asia Pacific

    Thai Diabetes Devices Market, Forecast to 2023

    The Professional Testing Segment will See a High Growth Rate of 10% in this High-cost Device Market

    Diabetes is a growing global concern, with more than 425 million people suffering the world over. Thailand is no exception. It has a high prevalence of about 8%; there were an estimated 4.25 million diabetics in the country in 2018. Unfortunately, only about 56% of this population is actually diagnosed, meaning almost half of those diabetics are di...

    $3,000.00
  7. 06 Feb 2020  |  Asia Pacific

    Indonesian Diabetes Devices Market, Forecast to 2023

    Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market

    Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...

    $3,000.00
  8. 06 Feb 2020  |  Asia Pacific

    Philippine Diabetes Devices Market, Forecast to 2023

    Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

    Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...

    $3,000.00
  9. 10 Jan 2020  |  Asia Pacific

    Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025

    Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry

    With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

    $10,000.00
  10. 21 Jun 2019  |  Asia Pacific

    Chinese In-vitro Diagnostics Market Insight, Forecast to 2023

    The China Manufacturing 2025 Program for Promoting Local R&D Investments and Increasing Demand from Tier I and II Hospitals Set to Transform the Industry Landscape

    The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

    $1,500.00